Botfet / Company detail

RMD

universe

ResMed

biotech

Moat score60out of 100

The numbers

Financial metrics

Quality gate and thesis context

Roic19.3%

Gross Margin61.1%

Revenue Cagr12.1%

Fcf Conversion108.3%

Fcf Yield4.6%

Interest Coverage0.0x

Market Cap B$35.6B

Pe24.2

Quality PassPass

Founder LedNo

Thesis AlignedYes

Moat Quant60

Why it may endure

Moat breakdown

Quant: 60 · Curator: 0

Market Share Stability12

Network Effects6

Pricing Power20

Regulatory Moat16

Switching Costs6

Conviction0/10

Leadership0/10

Vision0/10

← Back to the full screener